1. Home
  2. INM vs SMTI Comparison

INM vs SMTI Comparison

Compare INM & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • SMTI
  • Stock Information
  • Founded
  • INM 1981
  • SMTI 1982
  • Country
  • INM Canada
  • SMTI United States
  • Employees
  • INM N/A
  • SMTI N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • SMTI Medical/Dental Instruments
  • Sector
  • INM Health Care
  • SMTI Health Care
  • Exchange
  • INM Nasdaq
  • SMTI Nasdaq
  • Market Cap
  • INM 4.1M
  • SMTI 251.6M
  • IPO Year
  • INM N/A
  • SMTI N/A
  • Fundamental
  • Price
  • INM $1.72
  • SMTI $28.39
  • Analyst Decision
  • INM
  • SMTI Strong Buy
  • Analyst Count
  • INM 0
  • SMTI 2
  • Target Price
  • INM N/A
  • SMTI $50.00
  • AVG Volume (30 Days)
  • INM 74.5K
  • SMTI 25.8K
  • Earning Date
  • INM 11-13-2025
  • SMTI 11-12-2025
  • Dividend Yield
  • INM N/A
  • SMTI N/A
  • EPS Growth
  • INM N/A
  • SMTI N/A
  • EPS
  • INM N/A
  • SMTI N/A
  • Revenue
  • INM $4,942,633.00
  • SMTI $97,241,894.00
  • Revenue This Year
  • INM N/A
  • SMTI $24.49
  • Revenue Next Year
  • INM N/A
  • SMTI $14.43
  • P/E Ratio
  • INM N/A
  • SMTI N/A
  • Revenue Growth
  • INM 7.50
  • SMTI 34.29
  • 52 Week Low
  • INM $1.67
  • SMTI $23.53
  • 52 Week High
  • INM $8.27
  • SMTI $39.08
  • Technical
  • Relative Strength Index (RSI)
  • INM 27.48
  • SMTI 42.28
  • Support Level
  • INM $1.67
  • SMTI $28.30
  • Resistance Level
  • INM $1.92
  • SMTI $29.39
  • Average True Range (ATR)
  • INM 0.09
  • SMTI 1.23
  • MACD
  • INM -0.03
  • SMTI -0.16
  • Stochastic Oscillator
  • INM 8.73
  • SMTI 39.41

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: